POLQ and pancreatic ductal adenocarcinoma: Their study focuses on pancreatic ductal adenocarcinoma (PDAC), motivated by the observations that nearly a quarter of PDAC cases are associated with HR-associated gene alterations and that POLQ overexpression correlates with worse prognosis in two independent cohorts of PDAC patients.